In a proud recognition for Indian cardiology, Dr. B. Kesavamoorthy, Head of the Department of Cardiology at Meenakshi Hospital - Thanjavur was the only cardiologist from India to present at the prestigious ‘Cases with the Masters’ session at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Conference, held in San Francisco, USA, from October 25 to 28, 2025.
The TCT 2025 Conference, organised by the Cardiovascular Research Foundation (CRF), is the world’s premier educational forum in interventional cardiovascular medicine. Now in its 37th edition, TCT 2025 brought together thousands of clinicians, researchers, and innovators to share cutting-edge developments in cardiovascular science, technology, and practice.
The ‘Cases with the Masters’ session is one of the most anticipated highlights of the TCT Conference, where leading interventional cardiologists from around the world present their most challenging and innovative clinical cases before a panel of global experts. Dr. Kesavamoorthy was the only finalist from India to reach the global stage of this elite competition. His case, titled “The Handmade Covered Stent: For Type III Coronary Artery Perforation,” was recognised for its innovation and clinical precision in managing a rare and life-threatening coronary complication using a handmade stent creatively prepared to save patients.
This year, the conference received 912 case submissions from 54 countries, out of which 32 cases — 18 coronary, 8 structural, and 6 endovascular — were selected for the Grand Finale. Dr. Kesavamoorthy’s case went on to win the Runner-Up Award, bringing international recognition to Meenakshi Hospital Thanjavur and highlighting India’s growing stature in interventional cardiology.
In his comments, Dr. S. Gurushankar, Chairman, Meenakshi Hospital, said, “We are immensely proud of Dr. Kesavamoorthy for bringing this international honour to Meenakshi Hospital and to Thanjavur. His achievement at TCT 2025 is a great milestone in his long career and it is also a reflection of the culture of excellence and innovation we strive to build within our institution. At Meenakshi Hospital, we are committed to nurturing medical talent, investing in the latest technology, and continuously upgrading our facilities so that our patients have access to world-class cardiac care right here in Thanjavur.”
In his remarks, Dr. Kesavamoorthy said, “It is a great honour to receive this recognition at a global platform like TCT 2025. I dedicate this achievement to the management and team of Meenakshi Hospital, Thanjavur, whose support and collaboration made it possible. I am deeply grateful to my colleagues and patients, who constantly motivate me to do better each day. This moment is not just a recognition for one individual or one institution, but for all Indian cardiologists who continue to inspire through brilliance and commitment. This recognition reinforces my commitment to advancing patient care through innovation and teamwork.”
The Cardiovascular Research Foundation (CRF), which organises TCT, is a global leader dedicated to advancing interventional cardiovascular medicine through pioneering research, education, and innovation that improve patient outcomes and quality of life worldwide. The TCT is particularly renowned for its focus on real-world cases and its effort to blend theory with practice. The conference includes a unique format that begins with a clinical case and is followed by didactic sessions, helping integrate talks into the practical aspects of case-based learning.